In this issue:
Safety of systemic agents for paediatric psoriasis
Sleep disturbance in people with psoriasis
Secukinumab after up to 3 years of treatment
Prediction of long-term methotrexate outcome
European consensus on phenotypes of pustular psoriasis
Adalimumab in psoriasis patients with concomitant hepatitis B or C
Comparison of moderate-tosevere psoriasis and hidradenitis suppurativa
Methotrexate prescribing trends in Argentina
Multiple switches between etanercept and its biosimilar
Please login below to download this issue (PDF)